Mylan CEO Heather Bresch holds up Mylan EpiPen medication while speaking during a House Oversight and Government Reform Committee hearing Wednesday in Washington. Lawmakers questioned Bresch about how the company raised the price of the life-saving injection to $600 for a two-pack, from $57 a shot when it took over sales of the product in 2007.